Evaxion AS (EVAX)
3.20
+0.02
(+0.63%)
USD |
NASDAQ |
Oct 02, 16:00
3.25
+0.05
(+1.56%)
After-Hours: 20:00
Evaxion EPS Diluted (Quarterly) : -0.4464 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.4464 |
| March 31, 2026 | -0.4366 |
| December 31, 2025 | -0.8933 |
| September 30, 2025 | 0.7227 |
| June 30, 2025 | -0.7753 |
| March 31, 2025 | -0.2862 |
| December 31, 2024 | -3.144 |
| September 30, 2024 | -1.756 |
| June 30, 2024 | -1.145 |
| March 31, 2024 | 0.2554 |
| December 31, 2023 | -1.668 |
| September 30, 2023 | -2.042 |
| June 30, 2023 | -2.098 |
| March 31, 2023 | -2.431 |
| Date | Value |
|---|---|
| December 31, 2022 | -2.870 |
| September 30, 2022 | -2.396 |
| June 30, 2022 | -2.042 |
| March 31, 2022 | -2.490 |
| December 31, 2021 | -3.852 |
| September 30, 2021 | -2.726 |
| June 30, 2021 | -3.595 |
| March 31, 2021 | -2.294 |
| December 31, 2020 | -2.638 |
| September 30, 2020 | -2.228 |
| June 30, 2020 | -1.912 |
| March 31, 2020 | -9.565 |
| December 31, 2019 | -2.185 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Autolus Therapeutics Plc | -0.1472 |
| Cellectis SA | -0.2165 |
| Akari Therapeutics Plc | -2.404 |
| DBV Technologies SA | -0.5804 |
| Ascendis Pharma A/S | 3.522 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.724M |
| Total Expenses (Quarterly) | 3.724M |
| Enterprise Value | 19.79M |
| Earnings Yield | -32.92% |
| Normalized Earnings Yield | -33.08 |